112 related articles for article (PubMed ID: 25269739)
1. Designing innovative therapies for neuropathic pain: preclinical and early clinical development challenges.
Höke A; Simpson DM; Freeman R
J Peripher Nerv Syst; 2014 Oct; 19 Suppl 2():S28-9. PubMed ID: 25269739
[No Abstract] [Full Text] [Related]
2. Journal of the Peripheral Nervous System. Supplement: Designing innovative therapies for neuropathic pain: 2014 FPN International Research Symposium. Introduction.
Höke A; Simpson DM; Freeman R
J Peripher Nerv Syst; 2014 Oct; 19 Suppl 2():S1. PubMed ID: 25269726
[No Abstract] [Full Text] [Related]
3. Designing innovative therapies for neuropathic pain: pros and cons of target-based drug discovery.
Inglese J
J Peripher Nerv Syst; 2014 Oct; 19 Suppl 2(Suppl 2):S6-9. PubMed ID: 25269741
[No Abstract] [Full Text] [Related]
4. Current challenges and future prospects in management of neuropathic pain.
Jain KK
Expert Rev Neurother; 2008 Nov; 8(11):1743-56. PubMed ID: 18986244
[TBL] [Abstract][Full Text] [Related]
5. Novel clinical trial designs for innovative therapies.
Schellens JH; Beijnen JH
Clin Pharmacol Ther; 2009 Feb; 85(2):212-6. PubMed ID: 19109591
[No Abstract] [Full Text] [Related]
6. Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies.
Liu SV; Miller VA; Lobbezoo MW; Giaccone G
Eur J Cancer; 2014 Nov; 50(16):2747-51. PubMed ID: 25227487
[TBL] [Abstract][Full Text] [Related]
7. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.
Sawynok J
Eur J Pain; 2014 Apr; 18(4):465-81. PubMed ID: 24108446
[TBL] [Abstract][Full Text] [Related]
8. International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer.
Vassal G; Houghton PJ; Pfister SM; Smith MA; Caron HN; Li XN; Shields DJ; Witt O; Molenaar JJ; Colombetti S; Schüler J; Stancato LF
Mol Cancer Ther; 2021 Aug; 20(8):1462-1468. PubMed ID: 34108262
[TBL] [Abstract][Full Text] [Related]
9. Hyperbaric oxygen therapy attenuates neuropathic hyperalgesia in rats and idiopathic trigeminal neuralgia in patients.
Gu N; Niu JY; Liu WT; Sun YY; Liu S; Lv Y; Dong HL; Song XJ; Xiong LZ
Eur J Pain; 2012 Sep; 16(8):1094-105. PubMed ID: 22354664
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging of pain: advances and future prospects.
Stephenson DT; Arneric SP
J Pain; 2008 Jul; 9(7):567-79. PubMed ID: 18455479
[TBL] [Abstract][Full Text] [Related]
11. Future directions in neuropathic pain therapy: closing the translational loop.
Backonja M; Woolf CJ
Oncologist; 2010; 15 Suppl 2():24-9. PubMed ID: 20489194
[TBL] [Abstract][Full Text] [Related]
12. [Adaptive designs for innovative therapies assessment: New methodological challenges].
Asselain B
Bull Cancer; 2018 Sep; 105(9):741-742. PubMed ID: 30146086
[No Abstract] [Full Text] [Related]
13. Use of compassionate-case ATMP in preclinical data for clinical trial applications.
Lowdell MW; Birchall M; Thrasher AJ
Lancet; 2012 Jun; 379(9834):2341. PubMed ID: 22726516
[No Abstract] [Full Text] [Related]
14. Design and conduct of early clinical studies of two or more targeted anticancer therapies: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies.
Seymour LK; Calvert AH; Lobbezoo MW; Eisenhauer EA; Giaccone G;
Eur J Cancer; 2013 May; 49(8):1808-14. PubMed ID: 23428669
[TBL] [Abstract][Full Text] [Related]
15. Innovative reproductive technologies: risks and responsibilities.
Dondorp W; de Wert G
Hum Reprod; 2011 Jul; 26(7):1604-8. PubMed ID: 21502181
[TBL] [Abstract][Full Text] [Related]
16. Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT).
Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Eisenhauer EA; Seymour LK
Eur J Cancer; 2008 Jan; 44(1):25-9. PubMed ID: 17845846
[TBL] [Abstract][Full Text] [Related]
17. The critical path to medical innovation.
Williams D
Med Device Technol; 2004 Jun; 15(5):8-10. PubMed ID: 15285478
[TBL] [Abstract][Full Text] [Related]
18. [Placebo effect in randomized clinical trials in neuropathic pain patients].
Dobrogowski J; Ciupik M; Przeklasa-Muszyńska A; Wordliczek J
Folia Med Cracov; 2007; 48(1-4):125-44. PubMed ID: 19051699
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic pain.
Kerstman E; Ahn S; Battu S; Tariq S; Grabois M
Handb Clin Neurol; 2013; 110():175-87. PubMed ID: 23312640
[TBL] [Abstract][Full Text] [Related]
20. Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome?
Attal N; Bouhassira D; Baron R; Dostrovsky J; Dworkin RH; Finnerup N; Gourlay G; Haanpaa M; Raja S; Rice AS; Simpson D; Treede RD
Eur J Pain; 2011 May; 15(5):441-3. PubMed ID: 21458336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
